| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.082 | 0.09 |